252 related articles for article (PubMed ID: 34450043)
21. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
22. Structure of the type V-C CRISPR-Cas effector enzyme.
Kurihara N; Nakagawa R; Hirano H; Okazaki S; Tomita A; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Scott DA; Nishimasu H; Nureki O
Mol Cell; 2022 May; 82(10):1865-1877.e4. PubMed ID: 35366394
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas9 Structures and Mechanisms.
Jiang F; Doudna JA
Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
[TBL] [Abstract][Full Text] [Related]
24. Genome Engineering by RNA-Guided Transposition for
Arévalo S; Pérez Rico D; Abarca D; Dijkhuizen LW; Sarasa-Buisan C; Lindblad P; Flores E; Nierzwicki-Bauer S; Schluepmann H
ACS Synth Biol; 2024 Mar; 13(3):901-912. PubMed ID: 38445989
[TBL] [Abstract][Full Text] [Related]
25. Full-Length Model of SaCas9-sgRNA-DNA Complex in Cleavage State.
Du W; Zhu H; Qian J; Xue D; Zheng S; Huang Q
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674715
[No Abstract] [Full Text] [Related]
26. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
[TBL] [Abstract][Full Text] [Related]
27. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9.
Schuler G; Hu C; Ke A
Science; 2022 Jun; 376(6600):1476-1481. PubMed ID: 35617371
[TBL] [Abstract][Full Text] [Related]
29. An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity.
Wu T; Liu C; Zou S; Lyu R; Yang B; Yan H; Zhao M; Tang W
Nat Chem Biol; 2023 Nov; 19(11):1384-1393. PubMed ID: 37400536
[TBL] [Abstract][Full Text] [Related]
30. DNA interference states of the hypercompact CRISPR-CasΦ effector.
Pausch P; Soczek KM; Herbst DA; Tsuchida CA; Al-Shayeb B; Banfield JF; Nogales E; Doudna JA
Nat Struct Mol Biol; 2021 Aug; 28(8):652-661. PubMed ID: 34381246
[TBL] [Abstract][Full Text] [Related]
31. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic and evolutionary insights into a type V-M CRISPR-Cas effector enzyme.
Omura SN; Nakagawa R; Südfeld C; Villegas Warren R; Wu WY; Hirano H; Laffeber C; Kusakizako T; Kise Y; Lebbink JHG; Itoh Y; van der Oost J; Nureki O
Nat Struct Mol Biol; 2023 Aug; 30(8):1172-1182. PubMed ID: 37460897
[TBL] [Abstract][Full Text] [Related]
33. CasX enzymes comprise a distinct family of RNA-guided genome editors.
Liu JJ; Orlova N; Oakes BL; Ma E; Spinner HB; Baney KLM; Chuck J; Tan D; Knott GJ; Harrington LB; Al-Shayeb B; Wagner A; Brötzmann J; Staahl BT; Taylor KL; Desmarais J; Nogales E; Doudna JA
Nature; 2019 Feb; 566(7743):218-223. PubMed ID: 30718774
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of target site selection by type V-K CRISPR-associated transposases.
George JT; Acree C; Park JU; Kong M; Wiegand T; Pignot YL; Kellogg EH; Greene EC; Sternberg SH
Science; 2023 Nov; 382(6672):eadj8543. PubMed ID: 37972161
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for target site selection in RNA-guided DNA transposition systems.
Park JU; Tsai AW; Mehrotra E; Petassi MT; Hsieh SC; Ke A; Peters JE; Kellogg EH
Science; 2021 Aug; 373(6556):768-774. PubMed ID: 34385391
[TBL] [Abstract][Full Text] [Related]
37. DNA Targeting by a Minimal CRISPR RNA-Guided Cascade.
Hochstrasser ML; Taylor DW; Kornfeld JE; Nogales E; Doudna JA
Mol Cell; 2016 Sep; 63(5):840-51. PubMed ID: 27588603
[TBL] [Abstract][Full Text] [Related]
38. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
39. Structure of the IscB-ωRNA ribonucleoprotein complex, the likely ancestor of CRISPR-Cas9.
Kato K; Okazaki S; Kannan S; Altae-Tran H; Esra Demircioglu F; Isayama Y; Ishikawa J; Fukuda M; Macrae RK; Nishizawa T; Makarova KS; Koonin EV; Zhang F; Nishimasu H
Nat Commun; 2022 Nov; 13(1):6719. PubMed ID: 36344504
[TBL] [Abstract][Full Text] [Related]
40. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM.
Tang LC; Gu F
Yi Chuan; 2020 Mar; 42(3):236-249. PubMed ID: 32217510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
